Get notified when OTLK files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — Company now discloses substantial doubt about ability to continue operations due to insufficient cash to fund operations through the next 12 months.
- Delisting (new) — Company received Nasdaq deficiency notice for failing to maintain minimum $1.00 bid price and has until August 17, 2026 to regain compliance or face delisting.
- Securities Litigation (worsened) — Partial dismissal with prejudice indicates some claims survived and litigation continues with a third amended complaint.
Outlook Therapeutics flags going concern, misses debt payment, faces Nasdaq delisting
Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~2 min read
Key Changes
-
high
Company discloses substantial doubt about ability to continue operations, with $7.7M cash insufficient to fund next 12 months despite April 2026 financing adding $4.5M.
Risk Factors: Going Concern verify on EDGAR → -
high
Missed $3M quarterly debt payment on December 31, 2025, triggering Major Trigger Event; Avondale converted $6.9M at $0.46/share (80% below initial $2.26 conversion price), diluting shareholders with 15M new shares.
Risk Factors: Debt Default verify on EDGAR → -
high
Received Nasdaq deficiency notice February 18, 2026 for bid price below $1.00 for 30 days; must regain compliance by August 17, 2026 or face delisting to OTC markets.
Risk Factors: Nasdaq Delisting verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade OTLK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 27, 2026 · How we verify